News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
565,973 Results
Type
Article (45670)
Company Profile (120)
Press Release (520183)
Multimedia
Podcasts (82)
Webinars (12)
Section
Business (155420)
Career Advice (2411)
Deals (29034)
Drug Delivery (120)
Drug Development (71293)
Employer Resources (151)
FDA (15844)
Job Trends (12477)
News (278947)
Policy (30549)
Tag
2024 BioCapital Digital (5)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (9)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (4)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (3)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (2)
Academia (2369)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (82)
Alliances (37004)
ALS (89)
Alzheimer's disease (1453)
Antibody-drug conjugate (ADC) (138)
Approvals (15800)
Artificial intelligence (245)
Autoimmune disease (27)
Automation (12)
Bankruptcy (318)
Best Places to Work (9663)
BIOSECURE Act (22)
Biosimilars (114)
Biotechnology (72)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (268)
Cancer (2174)
Cardiovascular disease (189)
Career advice (2015)
Career pathing (33)
CAR-T (144)
Cell therapy (418)
Cervical cancer (20)
Clinical research (57975)
Collaboration (727)
Compensation (525)
Complete response letters (29)
COVID-19 (2643)
CRISPR (43)
C-suite (224)
Cystic fibrosis (97)
Data (2067)
Decentralized trials (2)
Denatured (14)
Depression (52)
Diabetes (272)
Diagnostics (5486)
Digital health (15)
Diversity (4)
Diversity, equity & inclusion (42)
Drug discovery (104)
Drug pricing (122)
Drug shortages (30)
Duchenne muscular dystrophy (97)
Earnings (66371)
Editorial (44)
Employer branding (20)
Employer resources (136)
Events (91790)
Executive appointments (661)
FDA (17071)
Featured Employer (33)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (655)
Gene editing (105)
Generative AI (22)
Gene therapy (320)
GLP-1 (799)
Government (4145)
Grass and pollen (6)
Guidances (55)
Healthcare (15612)
Huntington's disease (24)
IgA nephropathy (29)
Immunology and inflammation (141)
Indications (26)
Infectious disease (2789)
Inflammatory bowel disease (133)
Inflation Reduction Act (9)
Influenza (49)
Intellectual property (89)
Interviews (450)
IPO (14562)
IRA (48)
Job creations (3201)
Job search strategy (1672)
Kidney cancer (11)
Labor market (32)
Layoffs (512)
Leadership (23)
Legal (7184)
Liver cancer (73)
Lung cancer (310)
Lymphoma (148)
Machine learning (7)
Management (51)
Manufacturing (295)
MASH (70)
Medical device (11600)
Medtech (11603)
Mergers & acquisitions (14985)
Metabolic disorders (734)
Multiple sclerosis (79)
NASH (22)
Neurodegenerative disease (101)
Neuropsychiatric disorders (33)
Neuroscience (1997)
NextGen: Class of 2025 (5205)
Non-profit (3376)
Northern California (2517)
Now hiring (18)
Obesity (405)
Opinion (224)
Ovarian cancer (69)
Pain (87)
Pancreatic cancer (78)
Parkinson's disease (150)
Partnered (16)
Patents (231)
Patient recruitment (100)
Peanut (45)
People (44244)
Pharmaceutical (35)
Pharmacy benefit managers (21)
Phase I (17207)
Phase II (25199)
Phase III (20522)
Pipeline (1178)
Policy (166)
Postmarket research (2377)
Preclinical (7135)
Press Release (37)
Prostate cancer (110)
Psychedelics (36)
Radiopharmaceuticals (222)
Rare diseases (400)
Real estate (4409)
Recruiting (60)
Regulatory (21396)
Reports (32)
Research institute (2101)
Resumes & cover letters (402)
Rett syndrome (4)
RNA editing (3)
RSV (47)
Schizophrenia (76)
Series A (122)
Series B (80)
Service/supplier (10)
Sickle cell disease (54)
Southern California (2138)
Special edition (16)
Spinal muscular atrophy (132)
Sponsored (33)
Startups (2825)
State (1)
Stomach cancer (16)
Supply chain (73)
Tariffs (45)
The Weekly (67)
United States (21176)
Vaccines (768)
Venture capitalists (43)
Weight loss (295)
Women's health (31)
Worklife (20)
Date
Today (156)
Last 7 days (823)
Last 30 days (2512)
Last 365 days (30606)
2025 (10155)
2024 (32371)
2023 (36362)
2022 (46519)
2021 (50205)
2020 (47190)
2019 (38128)
2018 (28868)
2017 (28815)
2016 (27345)
2015 (30614)
2014 (24111)
2013 (19571)
2012 (21040)
2011 (21510)
2010 (19456)
Location
Africa (682)
Alabama (47)
Alaska (6)
Arizona (179)
Arkansas (10)
Asia (32402)
Australia (5667)
California (5681)
Canada (1609)
China (431)
Colorado (242)
Connecticut (269)
Delaware (133)
Europe (78609)
Florida (847)
Georgia (188)
Hawaii (1)
Idaho (39)
Illinois (459)
India (24)
Indiana (260)
Iowa (11)
Japan (149)
Kansas (85)
Kentucky (13)
Louisiana (7)
Maine (62)
Maryland (849)
Massachusetts (4283)
Michigan (188)
Minnesota (343)
Mississippi (1)
Missouri (73)
Montana (12)
Nebraska (19)
Nevada (57)
New Hampshire (53)
New Jersey (1616)
New Mexico (15)
New York (1593)
North Carolina (918)
North Dakota (6)
Northern California (2517)
Ohio (162)
Oklahoma (8)
Oregon (28)
Pennsylvania (1240)
Puerto Rico (10)
Rhode Island (21)
South America (1048)
South Carolina (20)
South Dakota (1)
Southern California (2138)
Tennessee (87)
Texas (796)
Utah (160)
Virginia (134)
Washington D.C. (60)
Washington State (514)
West Virginia (3)
Wisconsin (53)
565,973 Results for "kedrion s p a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kedrion Biopharma closes 2024 with a growth of +10% and unveils its new identity
April 14, 2025
·
6 min read
Press Releases
Kedrion Expands Ryplazim Distribution Network for PLGD-1 Patients
March 24, 2025
·
4 min read
FDA
Kedrion Selected by Biotest to Distribute its Immunoglobulin Yimmugo® in the U.S. Following Recent FDA Approval
Kedrion Biopharma Inc. announced that it has established the framework for a long-term agreement with Biotest AG for the full commercialization and distribution of the immunoglobulin therapy Yimmugo® in the U.S., following its Biologic License Application approval by the U.S. Food and Drug Administration on June 13, 2024.
July 1, 2024
·
5 min read
Pharm Country
Kedrion Announces Rare Disease Medicine RYPLAZIM® Now Available in US
Kedrion Biopharma Inc. announced today that plasminogen deficiency type 1 (PLGD-1) patients in the U.S. now have access to RYPLAZIM® (plasminogen, human-tvmh).
April 29, 2024
·
5 min read
Press Releases
FDA Approves Kedrion’s Bolognana Facility for Production of First and Only Treatment for PLGD-1, Ryplazim®
November 21, 2024
·
2 min read
Press Releases
Kedrion and Biotest complete long-term Exclusive Distribution Agreement for Yimmugo® in the US
October 2, 2024
·
5 min read
Business
Kamada Announces its Largest Commercial Agreement; A Strategic Engagement with Kedrion for U.S. Distribution of KEDRAB® including $180 Million of Revenues Over First Four Years
Kamada Ltd. announced the execution of a binding memorandum of understanding with Kedrion for the amendment and extension of the KEDRAB® U.S. distribution agreement between the parties.
December 6, 2023
·
8 min read
Press Releases
Kedrion Biopharma’s Focus on Advancing Patient Care in Rare Disease to be Showcased at NBDF Conference 2024
September 12, 2024
·
3 min read
Kedrion Announces an Eight-Year Extension of the Distribution Agreement With Kamada in the US for KEDRAB®
Kedrion Biopharma announces the execution of a binding memorandum of understanding with Kamada Ltd., an Israeli commercial stage global biopharmaceutical company and leader in the specialty plasma-derived field, for the amendment and the 8-year extension of the KEDRAB® US distribution agreement between the two companies.
December 7, 2023
·
5 min read
Pharm Country
Kedrion’s global portfolio expands to China to supply human Albumin
Kedrion Biopharma has announced that China’s National Institutes for Food and Drug Control has approved BPL’s human Albumin product for release to the Chinese market.
July 12, 2023
·
3 min read
1 of 56,598
Next
